NaviFUS begins neuronavigation-guided trial of FUS plus bevacizumab in rGBM patients
The trial will assess the safety and preliminary efficacy of repeated FUS-induced BBB opening with bevacizumab using NaviFUS…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
The trial will assess the safety and preliminary efficacy of repeated FUS-induced BBB opening with bevacizumab using NaviFUS…
The trial will validate the Vielight RX Plus as an effective therapeutic device to speed up the recovery…
The company has recently secured FDA breakthrough device status for the Intrepid TTVR system
The firm has filed an application with the FDA to provide the combined test via its Pixel by…
The qSanger-Covid-19 assay has been designed to eliminate the costly and time-consuming step of RNA extraction
The cobas SARS-CoV-2 & Influenza A/B Test facilitates the simultaneous qualitative detection and differentiation of SARS-CoV-2, Influenza A…
The funding will be used by Biofourmis to develop, validate and commercialise several released and unreleased digital therapeutics…
Ascyrus Medical Dissection Stent is said to be the world’s first aortic arch remodeling device to treat acute…
The rapid chromatographic immunoassay will facilitate the qualitative identification of a specific antigen of SARS-CoV-2 present in the…
The partnership will develop a Covid-19 serological test that can be used in different health care settings